[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:vaginal-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":163,"states":164},"Vaginal Carcinoma",25,23,[8,16,22,29,36,42,48,54,60,66,72,78,84,90,96,102,108,113,119,125,131,137,143,149,156],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06686043","HPV Vaccine, Imiquimod, and Metformin Combination Trial",[12],"Phase 2","RECRUITING","2026-08-26T02:19:19.975067Z","2026-05-05T02:43:28.177850Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05686226","E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers",[12],"2026-08-26T02:15:28.524219Z","2026-07-05T05:32:16.812867Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT05639972","E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:33.002248Z","2026-07-05T05:32:16.809101Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT04902443","Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV",[33],"Phase 1","2026-08-26T02:17:27.435233Z","2026-06-18T12:24:02.872345Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06677190","Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin",[12],"2026-08-26T02:17:03.534765Z","2026-05-05T02:43:29.398237Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05979610","Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies",[12],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:28.619575Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT02993900","Image-Guided Gynecologic Brachytherapy",[],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:27.038958Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[12],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT03968406","Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers",[33],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:26.771028Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05217940","Screening Women With Prior HPV for Anal Neoplasia",[],"2026-08-26T02:15:20.225313Z","2026-05-05T02:35:31.648507Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT07124000","DESTINY-PANTUMOUR04",[],"2026-08-26T02:15:24.145250Z","2026-05-13T02:55:06.658082Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06203106","NYSCF Scientific Discovery Biobank",[],"2026-08-26T02:15:57.572488Z","2026-05-13T02:55:06.425562Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT05394428","A Multi Center Study of Sexual Toxicities After Radiotherapy",[],"2026-08-26T02:16:40.941792Z","2026-05-13T02:55:06.304617Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT02012699","Integrated Cancer Repository for Cancer Research",[],"2026-08-26T02:16:35.654046Z","2026-05-13T02:55:06.082833Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT00005095","Specimen and Data Study for Ovarian Cancer Early Detection and Prevention",[],"2026-08-26T02:15:54.846520Z","2026-05-13T02:55:06.027521Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT05440760","Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy",[],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:27.961709Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":82,"content_modified":112},"NCT06936878","BOLSTER: Learning New Skills to Thrive",[],"2026-05-05T02:43:29.535284Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT07216456","Vaginal Dilator Therapy After Pelvic Radiation",[],"2026-08-26T02:18:05.435729Z","2026-05-05T02:43:29.340148Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT07407647","Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer",[12],"2026-08-26T02:16:29.226604Z","2026-05-05T02:43:28.133052Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT06339827","ASk Questions in GYnecologic Oncology (ASQ-GYO)",[],"2026-08-03T02:46:25.472834Z","2026-05-05T02:43:28.016172Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":20,"content_modified":136},"NCT07231588","Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation",[135],"Early Phase 1","2026-05-05T02:43:27.632971Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT05743517","Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)",[],"2026-08-26T02:18:18.766496Z","2026-05-05T02:43:26.946390Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT06059586","Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy",[],"2026-08-26T02:17:51.502023Z","2026-04-29T02:57:57.149666Z",{"nct_id":150,"title":151,"phases":152,"status":153,"updated_at":154,"content_modified":155},"NCT06694142","Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application",[],"NOT_YET_RECRUITING","2026-08-26T02:18:33.598205Z","2026-05-05T02:43:29.078926Z",{"nct_id":157,"title":158,"phases":159,"status":160,"updated_at":161,"content_modified":162},"NCT07118176","Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",[33],"ACTIVE_NOT_RECRUITING","2026-08-03T03:24:20.303158Z","2026-05-05T02:43:28.732453Z",[],[165,169,173,177,180,183,187,190],{"state":166,"count":167,"slug":168},"Texas",7,"texas",{"state":170,"count":171,"slug":172},"Maryland",5,"maryland",{"state":174,"count":175,"slug":176},"Illinois",4,"illinois",{"state":178,"count":175,"slug":179},"New York","new-york",{"state":181,"count":175,"slug":182},"Ohio","ohio",{"state":184,"count":185,"slug":186},"Florida",3,"florida",{"state":188,"count":185,"slug":189},"Massachusetts","massachusetts",{"state":191,"count":185,"slug":192},"North Carolina","north-carolina"]